THERAPEUTIC ANTI-HIV (VPR) COMPOUNDS

Title:

THERAPEUTIC ANTI-HIV (VPR) COMPOUNDS

Document Type and Number:

WIPO Patent Application WO2003037264

Kind Code:

A3

Abstract:

The present invention provides synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compositions of the invention.

More Like This:

WO/2023/180502	COMPOUND FOR INCREASING EFFICACY OF ONCOLYTIC VIRUSES
JP2003526342	Description: A novel method for diagnosing, monitoring, staging, imaging and treating breast cancer.
WO/1997/046682	POLYNUCLEOTIDES FROM HUMAN ADULT PBMC ENCODING SECRETED PROTEINS

Inventors:

NICOLETTE CHARLES A (US)
WALKER BRUCE D (US)

Application Number:

PCT/US2002/034688

Publication Date:

May 04, 2006

Filing Date:

October 29, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

GENZYME CORP (US)
TS GENERAL HOSPTIAL THE GENERA (US)
NICOLETTE CHARLES A (US)
WALKER BRUCE D (US)

International Classes:

A61K39/00; C07K14/16; C12N5/08; (IPC1-7): C07K7/00; C07K7/06; A61K38/08; C07H19/00; C07H21/00

Domestic Patent References:

WO1995026361A1

1995-10-05

Foreign References:

US5874225A

1999-02-23

Other References:

BARTZ ET AL.: "Human Immunodeficiency Virus Type 1 Cell Cycle Control: Vpr Is Cytostatic and Mediates G2 Accumulation by a Mechanism Which Differs from DNA Damage Checkpoint Control", JOURNAL OF VIROLOGY, vol. 70, no. 4, April 1996 (1996-04-01), pages 2324 - 2331, XP002983985

Download PDF:

View/Download PDF PDF Help

Previous Patent: SUNSPOT SKIN CREAM

Next Patent: METHOD OF TREATING VIRAL INFECTIONS